Table 2.
medical comorbidities and ASCVD risk among hypertensive participants attending an HIV treatment centre, northern Tanzania, 2018 (n = 91)
| Medical comorbidities and ASCVD risk identified by study criteria | |
|---|---|
| Diabetes mellitus, n (%) | |
| None | 58 (63.7%) |
| Pre-diabetes | 17 (18.7%) |
| Diabetes | 8 (8.7%) |
| Kidney disease (proteinuria present), n (%) | 26 (28.6%) |
| BMI categorization, n (%) | |
| Underweight | 2 (2.2%) |
| Normal weight | 23 (25.3%) |
| Overweight | 39 (42.9%) |
| Obese | 27 (29.7%) |
| Waist circumference (cm), mean (SD), n=90 | |
| Men | 97.7 (8.1) |
| Women | 93.5 (10.2) |
| Central obesity present (yes), n=90, n (%) | 78 (86.7%) |
| 10-year ASCVD risk, n=74, median (IQR) | 8.1% (4.3% - 15.9%) |
| 10-year ASCVD risk categorization, n=74, n (%) | |
| Low risk < 5.0% | 22 (29.7%) |
| Borderline risk 5.0% - 7.4% | 13 (17.6%) |
| Intermediate risk 7.5% - 19.9% | 25 (33.8%) |
| High risk > 20.0% | 14 (18.9%) |
Sample size is 91 participants unless otherwise stated. Abbreviations: ASCVD: atherosclerotic cardiovascular disease; BMI: body mass index; SD: standard deviation; IQR: interquartile range